Generic Name: vorinostat
Brand Name: Zolinza
Manufacturer: Merck Canada Inc.
Therapeutic Area: Cutaneous T-cell lymphoma
Indications: For the treatment of cutaneous manifestations in patients with advanced cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease subsequent to prior systemic therapies.
Submission Type: Non-submission
Project Status: Not filed
Recommendation Type: CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer